CoChat

Gene co-expression analysis for functional classification and gene–disease predictions

Open access

The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index; 104 of the 126 sources its claims cite were checked for support.

Abstract

Gene co-expression networks can be used to associate genes of unknown function with biological processes, to prioritize candidate disease genes or to discern transcriptional regulatory programmes. With recent advances in transcriptomics and next-generation sequencing, co-expression networks constructed from RNA sequencing data also enable the inference of functions and disease associations for non-coding genes and splice variants. Although gene co-expression networks typically do not provide information about causality, emerging methods for differential co-expression analysis are enabling the identification of regulatory genes underlying various phenotypes. Here, we introduce and guide researchers through a (differential) co-expression analysis. We provide an overview of methods and tools used to create and analyse co-expression networks constructed from gene expression data, and we explain how these can be used to identify genes with a regulatory role in disease. Furthermore, we discuss the integration of other data types with co-expression networks and offer future perspectives of co-expression analysis.

Overview

CoChat Summary

TL;DR

This review guides researchers through (differential) co-expression analysis of gene expression data, especially RNA-seq, for functional classification and gene–disease prediction. It surveys network construction, module and hub detection, differential co-expression, and multi-omics integration, emphasizing that co-expression alone is correlative but can prioritize regulatory candidates when integrated with other data.

Key findings

  • RNA-seq-based co-expression can assign putative functions to non-coding RNAs and splice variants and identify disease candidates; RNA-seq quantifies the over 70,000 non-coding RNAs not usually measured with microarrays, and a 20-sample minimum has been suggested for co-expression networks, with 10 million reads per sample commonly used as a cut-off.
  • Hub genes have limited power for identifying causal targets: one myocardial study using 1,617 samples found known foetal gene markers upregulated in disease networks were not hub genes, and Salmonella hub genes were dispensable for growth, stress adaptation and virulence. In guilt-by-association, the fraction of module genes related to the main biological function is often <20%, and module–trait correlations can be <0.5 even when statistically significant.
  • Differential co-expression can uncover regulators: in mutant cattle, differential wiring identified the causal mutation in myostatin (Mstn) even though Mstn expression itself hardly changed; biclustering of single-cell RNA-seq data identified 49 different cell types and corresponding cell-type-specific gene modules.
  • Integrating other data layers—GWAS hits, eQTLs, TFBSs, methylation, protein–protein interactions—increases prediction accuracy; cis-eQTL-anchored co-expression identified TYROBP as the most likely causal factor in late-onset Alzheimer disease, supported by known Nasu-Hakola disease mutations in this gene.

Methods

  • Design: narrative review and practical guide; no new primary experiment or dataset is generated. It synthesizes methods and tools for constructing and analysing co-expression networks from microarray and RNA-seq data, with a focus on differential co-expression.
  • Data or sample: literature and existing tools/databases, including WGCNA, DICER, DiffCoEx, GSVD, biclustering, COXPRESdb, GeneFriends, GeneMANIA, GENEVESTIGATOR and GIANT; no primary sample or dataset was collected.
  • Main analysis: describes the three-step construction of co-expression networks (pairwise correlation or mutual information, network representation, clustering into modules), module/hub/guilt-by-association interpretation, differential co-expression between predefined groups or via biclustering/GSVD, and integration with multi-omics data.

Limitations

  • The paper states that co-expression networks identify correlations, not causality, and normally cannot distinguish regulatory from regulated genes; hub genes are not guaranteed to be causal or essential.
  • The paper states that differential co-expression methods are sensitive to noise and outliers and require high-quality data; comparison is difficult because of a lack of gold-standard gene sets, and normalization or mapping-tool choices can affect results. Single-cell RNA-seq faces sparse expression matrices, low reads per cell, and normalization methods not attuned to these data.
  • Evident from the text: as a narrative review, it does not perform a systematic, unbiased comparison of all tools; the authors note that comprehensive comparison is desirable but difficult and likely situation-dependent.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/bib/bbw139

Cites

181 of 181 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Example of a co-expression network analysis. First, pairwise correlation is determined for each possible gene pair in the expression data. These pairwise correlations can then be represented as a network. Modules within these networks are defined using clustering analysis. The network and modules can be interrogated to identify regulators, functional enrichment and hub genes. Differential co-expression analysis can be used to identify modules that behave differently under different conditions. Potential disease genes can be identified using a guilt-by-association (GBA) approach that highlights genes that are co-expressed with multiple disease genes.
Figure 1 Example of a co-expression network analysis. First, pairwise correlation is determined for each possible gene pair in the expression data. These pairwise correlations can then be represented as a network. Modules within these networks are defined using clustering analysis. The network and modules can be interrogated to identify regulators, functional enrichment and hub genes. Differential co-expression analysis can be used to identify modules that behave differently under different conditions. Potential disease genes can be identified using a guilt-by-association (GBA) approach that highlights genes that are co-expressed with multiple disease genes.CC BY · PubMed Central
Figure 2 Hypothetical network explaining inter- and intra-modular hubs and network centrality. The inter-modular hub has a high network centrality, as it is required for the largest number of shortest paths between all possible node pairs. The red line indicates an example of a shortest path through the network between a pair of nodes. Intra-modular hubs (marked with orange) are central to individual modules and usually have high biological relevance.
Figure 2 Hypothetical network explaining inter- and intra-modular hubs and network centrality. The inter-modular hub has a high network centrality, as it is required for the largest number of shortest paths between all possible node pairs. The red line indicates an example of a shortest path through the network between a pair of nodes. Intra-modular hubs (marked with orange) are central to individual modules and usually have high biological relevance.CC BY · PubMed Central
Figure 3 Changes in gene co-expression patterns that can occur between samples. Differential co-expression can occur as the presence of a module in only one of the sample groups (A), as differences in the structure of the module (B) or as differences in the correlation strength between members of the modules (C). Additionally, differential co-expression can be detected if one larger interconnected module splits into several smaller ones (D) or if a group of genes changes its correlation partners [‘gene hopping’ (E)]. If sample groups are not defined before the differential co-expression analysis, or are unknown, biclustering methods can identify modules unique to a subpopulation of samples by simultaneously classifying the samples into groups in which these modules exist (F).
Figure 3 Changes in gene co-expression patterns that can occur between samples. Differential co-expression can occur as the presence of a module in only one of the sample groups (A), as differences in the structure of the module (B) or as differences in the correlation strength between members of the modules (C). Additionally, differential co-expression can be detected if one larger interconnected module splits into several smaller ones (D) or if a group of genes changes its correlation partners [‘gene hopping’ (E)]. If sample groups are not defined before the differential co-expression analysis, or are unknown, biclustering methods can identify modules unique to a subpopulation of samples by simultaneously classifying the samples into groups in which these modules exist (F).CC BY · PubMed Central
Figure 4 Strategies for integrating multi-omics data with co-expression analyses. Networks are more informative if they are constructed using expression data specific to the tissue of interest. Genomic variation can be mapped to a co-expression network either by linking suggestive GWAS hits to the genes in the network or by first identifying genetic variants with an effect on gene expression levels (cis- and trans-eQTLs) and then mapping those to the co-expression network. Additional data layers may include TFBSs (based on binding motifs or ChIP-seq/ChIP-chip experiments), miRNA target binding sites (based on in silico predictions or experimental techniques) and established protein–protein interactions. A co-expression network can be used to identify modules, hub genes and for predicting the function of unknown trait-associated genes. Identified modules can be analysed by enrichment analyses to identify overlaying features. Additionally, the research hypothesis can be supported by additional differential expression, co-expression and methylation analyses that can be performed if respective omics data are available for cases and controls for a corresponding trait. eQTL: expression quantitative trait loci; GWAS: genome-wide association study; OMIM: online Mendelian inheritance in man; miRNA: microRNA; PPI: protein–protein interaction; TF: transcription factor; TFBS: TF binding site.
Figure 4 Strategies for integrating multi-omics data with co-expression analyses. Networks are more informative if they are constructed using expression data specific to the tissue of interest. Genomic variation can be mapped to a co-expression network either by linking suggestive GWAS hits to the genes in the network or by first identifying genetic variants with an effect on gene expression levels (cis- and trans-eQTLs) and then mapping those to the co-expression network. Additional data layers may include TFBSs (based on binding motifs or ChIP-seq/ChIP-chip experiments), miRNA target binding sites (based on in silico predictions or experimental techniques) and established protein–protein interactions. A co-expression network can be used to identify modules, hub genes and for predicting the function of unknown trait-associated genes. Identified modules can be analysed by enrichment analyses to identify overlaying features. Additionally, the research hypothesis can be supported by additional differential expression, co-expression and methylation analyses that can be performed if respective omics data are available for cases and controls for a corresponding trait. eQTL: expression quantitative trait loci; GWAS: genome-wide association study; OMIM: online Mendelian inheritance in man; miRNA: microRNA; PPI: protein–protein interaction; TF: transcription factor; TFBS: TF binding site.CC BY · PubMed Central

Verification

Claims the paper makes

67 Valid · 8 Not valid · 6 Not checked · 39 Own results and interpretations

53 more claims · 34 with their cited sources checked

Create a free account to see all 120 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 30
  • Probably not a substantial claim. 36

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 995

Metadata

Authors
van Dam, S., Võsa, U., van der Graaf, A., Franke, L., & de Magalhães, J. P.
Affiliations
  • University Medical Center Groningen (NL)
  • University of Liverpool (GB)
Corresponding author
  • van Dam, Sipko
  • de Magalhães, João Pedro
Venue
Briefings in Bioinformatics
Published
2017-01-10
Volume
19
Issue
4
Pages
bbw139
ISSN
  • 1467-5463 (ISSN-L)
  • 1477-4054
OpenAlex
W2577490495
Cited by
995
References
181
Citations by year
2026: 47 · 2025: 92 · 2024: 111 · 2023: 116 · 2022: 138 · 2021: 159 · 2020: 135 · 2019: 125 · 2018: 51 · 2017: 20
FWCI
25.09
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Briefings in Bioinformatics (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
  • University of Liverpool
  • Rijksuniversiteit Groningen
  • Universitair Medisch Centrum Groningen
  • Directorate for Biological Sciences
  • Biotechnology and Biological Sciences Research Council (BB/K016741/1)
  • H2020 European Research Council (637640)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
Keywords
gene co-expression network, gene function prediction, disease gene prioritization, gene-disease association, non-coding genes, splice variants, transcriptional regulation, multi-omics integration, RNA sequencing
MeSH terms
Disease, Gene Expression Regulation, Genes, Humans, Phenotype, Computational Biology, Gene Expression Profiling, Gene Regulatory Networks

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.